While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy. Many of the biggest public companies, especially the technology giants, trade in the hundreds, all the way up to over $1,000 per share or more. At those steep prices, it is difficult to get any decent share count leverage.
[in-text-ad]
Many investors, especially more aggressive traders, look at lower-priced stocks as a way not only to make some good money but to get a higher share count. That can really help the decision-making process, especially when you are on to a winner, as you can always sell half and keep half.

Skeptics of low-priced shares should remember that at one point Amazon, Apple and Netflix traded in the single digits. Nvidia, which has exploded higher on AI semiconductor chips, traded under $10 for years. One stock we featured over the years, Zynga, was purchased by Take-Two Interactive. Cogent Biosciences, which we featured last March, has tripled since then.

We screened our 24/7 Wall St. research database looking for smaller cap companies that could offer patient investors some huge returns for 2023 and beyond. While these five stocks are rated Buy and have a ton of Wall Street coverage, it is important to remember that no single analyst report should be used as a sole basis for any buying or selling decision.

Dish Network

This satellite provider has always been rumored to be a takeover target. Dish Network Corp. (NASDAQ: DISH) provides pay-TV services in the United States. It offers video services under the Dish TV brand, and its programming packages include programming through national broadcast networks, local broadcast networks, and national and regional cable networks, as well as regional and specialty sports channels, premium movie channels and Latino and international programming packages.

The company also provides access to movies and television shows through TV or Internet-connected devices; and dishanywhere.com and mobile applications on Internet-connected devices to view authorized content, search program listings, and remotely control certain features of their DVRs.

In addition, it offers Sling TV services, including Sling domestic, Sling International, Sling Latino, Sling Orange and Sling Blue services that require an internet connection and are available on streaming-capable devices, such as streaming media devices, TVs, tablets, computers, game consoles and phones. Its markets Sling TV services to consumers who do not subscribe to traditional satellite and cable pay-TV services.

Further, the company provides wireless subscribers consumer plans with no annual service contracts, as well as monthly service plans, including high-speed data and unlimited talk and text. The company offers receiver systems and programming through direct sales channels, as well as independent third parties, such as small retailers, direct marketing groups, local and regional consumer electronics stores, retailers, and telecommunications companies.

J.P. Morgan has a $16 target price on Dish Network stock. The consensus target is $16.86, and shares closed at $6.02 on Friday.

This energy stock offers a solid dividend and good exposure to the sector, and it may be poised to be a big winner from provisions in the debt ceiling bill. Equitrans Midstream Corp. (NYSE: ETRN) owns, operates, acquires and develops natural gas gathering, transmission and storage, and water services assets in the Appalachian Basin. It operates through these three segments:
[in-text-ad]

• Gathering System: This segment includes 1,130 miles of high-pressure gathering lines with compression of approximately 485,000 horsepower and multiple interconnect points, as well as approximately 910 miles of Federal Energy Regulatory Commission (FERC) low-pressure gathering lines.
• Transmission and Storage System: This segment comprises 950 miles of FERC-regulated interstate pipeline that connects to seven interstate pipelines and local distribution companies.
• Water Service System: This segment includes two independent systems, comprising approximately 200 miles of pipeline that deliver fresh water from the Monongahela River, the Ohio River, local reservoirs and various regional waterways.

Shareholders receive a 9.85% dividend. Wolfe Research has set its price target at $11. Equitrans Midstream stock has a consensus target of $10.13. The shares closed on Friday at $9.04 apiece.

Peloton Interactive

This cycling and exercise platform was a huge pandemic winner but has been hammered this past year. Peloton Interactive Inc. (NASDAQ: PTON) operates interactive fitness platforms in North America and internationally. The company offers connected fitness products with touchscreens that stream live and on-demand classes under the Peloton Bike, Peloton Bike+, Peloton Tread and Peloton Tread+ names.

The company also provides connected fitness subscriptions for various household users and access to various live and on-demand classes. Its Peloton Digital app for connected fitness subscribers provides access to its classes. As of June 30, 2022, it had approximately 6.9 million members. The company markets and sells its interactive fitness products directly through its retail showrooms and online.

The company announced last November a partnership with Dick’s Sporting Goods to sell their exercise bikes through the retail giant. Peloton’s exercise hardware (minus its new rowing machine) is available for sale at 100 Dick’s Sporting Goods locations.

The BofA Securities target price is $13, while the consensus target was last seen at $12.13. Peloton Interactive stock closed at $7.31 on Friday.

Plug Power

This company is poised to be a huge winner in the fuel cell battle for electric vehicles (EVs). Plug Power Inc. (NASDAQ: PLUG) delivers end-to-end clean hydrogen and zero-emissions fuel cell solutions for supply chain and logistics applications, on-road EVs, the stationary power market and others in North America and internationally. It engages in building an end-to-end green hydrogen ecosystem, including liquid green hydrogen production, storage and handling, transportation and dispensing infrastructure.

The company offers the following:

• GenDrive, a hydrogen-fueled proton exchange membrane (PEM) fuel cell system that provides power to material handling electric vehicles
• GenFuel, a liquid hydrogen fueling delivery, generation, storage and dispensing system
• GenSure, a stationary fuel cell solution that offers modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation and utility sectors

• GenKey, an integrated turn-key solution for transitioning to fuel cell power
• ProGen, a fuel cell stack and engine technology used in mobility and stationary fuel cell systems, and as engines in electric delivery vans; liquefaction systems; and electrolyzers that are hydrogen generators optimized for clean hydrogen production
• GenCare, an ongoing Internet of Things-based maintenance and on-site service program for GenDrive and GenSure fuel cell systems, GenFuel hydrogen storage and dispensing products and ProGen fuel cell engines

[in-text-ad]
The company sells its products through a direct product sales force, original equipment manufacturers and dealer networks.

Plug Power stock has a $24 target price at UBS. The consensus target is lower at $19.00. On Friday, shares last traded at $9.20 apiece.

Teva Pharmaceutical

This leading generic drug maker is trading at 25-year lows and could be a steal at current prices. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) develops, manufactures, markets and distributes generic medicines, specialty medicines and biopharmaceutical products in North America, Europe and elsewhere.

The company offers sterile products, hormones, high-potency drugs and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments and creams. It also manufactures and sells active pharmaceutical ingredients, as well as provides contract manufacturing services, and it operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition, it focuses on the central nervous system (CNS), pain, respiratory and oncology areas.

The company’s products portfolio in the CNS field includes Copaxone for the treatment of relapsing forms of multiple sclerosis, Ajovy for the preventive treatment of migraine in adults and Austedo for the treatment of neurodegenerative and movement disorders associated with Huntington’s disease and tardive dyskinesia.

In the respiratory therapeutic area, products include ProAir RespiClick, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, Braltus, Cinqair/Cinqaero, DuoResp Spiromax and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease.

Oncology therapeutic offerings consist of Bendeka, Treanda, Granix, Trisenox, Lonquex and Tevagrastim/Ratiograstim.

Teva has a collaboration with MedinCell for the development and commercialization of multiple long-acting injectable products and a risperidone suspension for the treatment of patients with schizophrenia.

The $14 Barclays target price is well above the $9.69 consensus target, and Teva Pharmaceutical Industries stock closed at $7.62 on Friday.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with absolutely no track record or liquidity, and major Wall Street firms have research coverage.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.